Clinical and Ultrasound Evaluation
A testicular mass may be assessed by examination and ultrasound, with serum tumor markers collected as part of the wider workup.
Testicular Cancer Pathology Support
Understanding Your Testicular Cancer Pathology Report
Get a clearer explanation of the diagnosis, seminoma or nonseminomatous components, tumor percentages, size, lymphovascular invasion, rete testis or hilar involvement, spermatic-cord margin, germ cell neoplasia in situ, and other findings documented in your report.
This educational consultation explains your existing written pathology report. It does not provide a new diagnosis, written report, official document, treatment plan, or replacement for your treating clinicians.
Understand what your report documentsAnd what may still depend on serum tumor markers, imaging, surgery, additional specimens, or other clinical information.
Board-Certified PathologistProfessional pathology-report guidance
Secure Virtual AppointmentMeet online from the comfort of home
Patient-Friendly ExplanationClear language for complex report findings
Educational SupportNot a replacement for medical advice
Understanding the Process
How a Testicular Cancer Diagnosis Is Established
Examination, ultrasound, and serum tumor markers can identify concern, but microscopic examination of the orchiectomy specimen usually establishes and classifies a testicular germ cell tumor.
Radical Inguinal Orchiectomy
The testicle is removed through the groin for diagnosis and local pathologic assessment in the usual pathway for a suspicious intratesticular mass.
Pathology Diagnosis
The pathologist identifies seminoma, nonseminomatous components, or a mixed germ cell tumor and documents specimen-specific extent.
Wider Clinical Assessment
Pathology, pre- and post-orchiectomy tumor markers, imaging, and health history are considered together by the care team.
Serum tumor markers are not microscopic findings. AFP, beta-hCG, and LDH are blood tests used with pathology and imaging. Their values and timing are interpreted by the treating team.
Different Reports, Different Questions
Orchiectomy Versus Later-Site Pathology
The orchiectomy report defines the primary testicular tumor and local extent. A later lymph-node, retroperitoneal-dissection, or metastatic-site specimen answers different questions.
Primary Tumor Specimen
Radical-Orchiectomy Report
The report evaluates the testis, attached structures, and spermatic-cord margin.
- Histologic type and component percentages
- Tumor size and focality
- Lymphovascular invasion
- Rete testis, hilum, epididymis, tunica, or cord involvement
- GCNIS and margin status
Additional Submitted Tissue
Lymph-Node or Metastatic-Site Report
A later specimen may document tumor at another site or changes after therapy.
- Specimen site and procedure
- Viable tumor type or components
- Treatment effect or necrosis when applicable
- Number and size of involved lymph nodes
- Margins or extranodal extension when relevant
Inside the Report
What Your Testicular Cancer Pathology Report May Tell You
The findings depend on the specimen. An orchiectomy, retroperitoneal lymph-node dissection, or biopsy from another site will not contain the same report elements.
Read every component in a mixed germ cell tumor.
A mixed tumor may contain seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, or other components. The report may estimate the percentage of each.
Diagnosis and Histologic Type
The report identifies seminoma, a nonseminomatous germ cell tumor, a mixed germ cell tumor, or another testicular neoplasm.
Component Percentages
For mixed germ cell tumors, the approximate proportion of each histologic component may be documented.
Tumor Size and Focality
The report records the largest tumor dimension and whether one or multiple tumor nodules are present.
Lymphovascular Invasion
Tumor within lymphatic or blood vessels is reported because it contributes to local pathologic classification.
Rete Testis and Hilar Soft Tissue
The report may distinguish stromal invasion of the rete testis from pagetoid spread and assess hilar soft-tissue involvement.
Epididymis, Tunica, and Spermatic Cord
Extension into these structures is documented separately according to what is present in the specimen.
Spermatic-Cord Margin
The report states whether tumor reaches the spermatic-cord resection margin or another designated margin.
Germ Cell Neoplasia In Situ
GCNIS is a precursor lesion associated with many testicular germ cell tumors and may be recorded in the surrounding testis.
Need Help Understanding These Findings?
Review the tumor type, component percentages, lymphovascular invasion, local extent, margins, GCNIS, specimen limitations, and pending results in your existing testicular pathology report.
pTisGerm cell neoplasia in situ
pT1Limited findings without lymphovascular invasion
pT2Lymphovascular invasion or specified local extension
pT3Spermatic-cord invasion
pT4Scrotal invasion
Understanding Local Extent
How Testicular Tumor pT Categories Describe the Primary Site
The orchiectomy pT category uses local anatomic involvement and lymphovascular invasion. Complete stage also uses lymph nodes, distant spread, and serum tumor-marker information.
Lymphovascular Invasion Can Change pT
The presence of tumor in lymphatic or blood vessels is a key distinction between pT1 and pT2 for many germ cell tumors.
Exact Anatomic Wording Matters
Rete testis, hilar soft tissue, epididymis, tunica vaginalis, spermatic cord, and scrotum are separate report elements.
Complete Stage Uses More Than pT
Serum tumor markers and imaging contribute information that is not supplied by the orchiectomy pathology report alone.
After Orchiectomy
Findings That Help Describe Pathologic Extent
The orchiectomy report maps tumor within the testis and attached structures. These findings are interpreted with histologic type, tumor markers, imaging, and the wider clinical case.
Lymphovascular Invasion
Tumor cells within endothelial-lined spaces are documented and can affect the primary-tumor category.
Rete Testis and Hilum
The report may describe stromal rete testis or hilar soft-tissue invasion using specific criteria.
Tunica and Epididymis
Tumor involvement of the tunica vaginalis or epididymis is documented separately from other local findings.
Spermatic Cord and Margin
Direct invasion of the spermatic cord and involvement of the cord margin are distinct report elements.
Nodes, Markers, and Complete Stage
A lymph-node specimen may provide pN information, while serum AFP, beta-hCG, and LDH contribute a separate marker category. Complete staging requires these elements and imaging.
Additional Testing
Immunohistochemistry, Serum Markers, and Molecular Studies
Different tests answer different questions. Some are performed on tissue, while AFP, beta-hCG, and LDH are measured in blood.
Diagnostic Immunohistochemistry
Immunostains may help distinguish seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, and other components.
IHCTumor type
Serum Tumor Markers
AFP, beta-hCG, and LDH are blood tests interpreted according to timing and the wider clinical situation; they are not produced by the pathology report.
AFP / hCGLDH
Molecular or Cytogenetic Testing
Selected difficult or metastatic cases may use studies such as chromosome 12p assessment to support germ cell tumor classification.
12pSelected cases
Tissue findings and serum markers must be correlated. For example, an elevated AFP is not expected from pure seminoma and prompts clinical-pathologic correlation. A consultation explains documented results without diagnosing from blood tests or recommending therapy.
Questions About Tumor Components or Additional Tests?
Get a patient-friendly explanation of findings already documented in your pathology and laboratory reports and identify which results may still be pending or separate.
Putting the Results Together
What Is Confirmed, Pending, or Dependent on Other Information?
An orchiectomy pathology report provides essential information, but complete staging and treatment planning require additional clinical data.
Confirmed in the Report
Documented Pathology Findings
The tumor type, component percentages, size, lymphovascular invasion, local extent, margins, and GCNIS may be documented when assessable.
May Still Be Pending
Addenda or Separate Results
Immunohistochemistry, molecular studies, outside consultation, lymph-node pathology, or another specimen may be pending or separately reported.
Requires Wider Context
Markers, Imaging, and Care Planning
Serum tumor markers, imaging, operative findings, health history, and evaluation by the treating team provide wider context.
How HONEST Pathology Helps
A Clearer Explanation of the Report You Already Have
A pathology report consultation helps you understand terminology and findings already documented, so you can approach conversations with your treating team with greater context and more focused questions.
Upload Your Reports and Records
Submit the pathology report and relevant records requested for the consultation.
Meet Online With a Pathologist
Discuss the report during a private virtual appointment and ask questions about the documented findings.
Receive a Plain-Language Explanation
Better understand the terminology and prepare questions to discuss with your treating care team.
Consultation Scope
What the Consultation Includes and Excludes
A report explanation and a formal microscopic second opinion are different services. Clear boundaries help you choose the appropriate option.
The Consultation May Explain
- The documented testicular tumor diagnosis and terminology
- Differences between orchiectomy and later-site pathology reports
- Seminoma, nonseminomatous, and mixed-tumor components
- Component percentages, size, and lymphovascular invasion
- Rete testis, hilum, epididymis, tunica, cord, margins, and GCNIS
- Immunostains, molecular studies, and related documented laboratory results
- Questions to discuss with your treating team
The Consultation Does Not Include
- A new pathology diagnosis or replacement interpretation
- A new written report or official document
- Complete staging or risk classification from pathology alone
- Treatment prescribing or replacement of the medical care team
- Physical examination, imaging review, or tumor-marker interpretation in isolation
- Microscopic slide review unless a separate pathology second-opinion service is ordered
Choosing the Right Service
Report Consultation or Formal Pathology Second Opinion?
The right option depends on whether you need help understanding written results or an independent review of pathology slides, tissue, or digital images.
Frequently Asked Questions
Questions About Testicular Cancer Pathology Reports
These answers provide general educational information. Individual reports vary according to specimen, procedure, tumor type, prior treatment, additional testing, and wider clinical situation.
What is the difference between seminoma and nonseminoma?
They are major categories of testicular germ cell tumor with different microscopic components and clinical implications. A mixed germ cell tumor contains more than one component.
Why does the report list tumor percentages?
For a mixed germ cell tumor, the estimated proportion of each component documents the composition of the tumor in the examined specimen.
What does lymphovascular invasion mean?
It means tumor is identified within lymphatic or blood vessels according to microscopic criteria and can affect the local pT category.
What is germ cell neoplasia in situ?
GCNIS is a precursor lesion associated with many testicular germ cell tumors and may be identified in testicular tissue surrounding the invasive tumor.
Are AFP, beta-hCG, and LDH part of pathology?
They are serum laboratory tests, not microscopic tissue findings. Their values and timing are interpreted with pathology and imaging by the treating team.
What does the spermatic-cord margin mean?
It is the cut edge of the removed spermatic cord. The report states whether tumor reaches that designated margin.
Can the orchiectomy report provide the complete stage?
Not by itself. Complete stage also depends on lymph-node or distant-disease information, imaging, and post-orchiectomy serum tumor markers.
When is a formal pathology second opinion more appropriate?
A formal second opinion may be appropriate when findings are complex, uncertain, unexpected, or when independent examination of the original slides or tissue could provide additional value.
Clearer Answers Begin Here
Understand the Findings in Your Testicular Pathology Report
Meet online with a pathologist who can explain the tumor type, component percentages, lymphovascular invasion, local extent, margins, GCNIS, specimen limitations, and questions raised by your existing report.
Educational support only. This service does not replace your treating physician, urologist, oncologist, surgeon, radiologist, reproductive specialist, or medical care team.
